Lu­men lands an­oth­er DoD con­tract to treat Covid-re­lat­ed GI is­sues

4 years ago
Deals
Coronavirus

The FDA adds a failed Alzheimer's drug to the 'break­through' club now look­ing for a near-term OK

4 years ago
FDA+

Af­ter skep­ti­cism and tight vote at ad­comm, FDA ap­proves Chemo­Cen­tryx's rare dis­ease drug

4 years ago
FDA+

Mi­rati teams with Sanofi on PhI/II tri­al for KRAS treat­ment com­bo; Ab­b­Vie los­es in lat­est Hu­mi­ra biosim­i­lar ...

4 years ago
News Briefing

Re­lay un­rolls ear­ly da­ta for an­ti-FGFR drug it thinks stand alone in terms of safe­ty pro­file

4 years ago
R&D

New­ly re­vealed texts from ex-FDA leader Stephen Hahn of­fer be­hind-the-scene glimpse in­to Trump’s Covid scare

4 years ago
FDA+

Care about R&D strate­gies? Have we got a sum­mit for you

4 years ago
Bioregnum

Covid-19 roundup: Pfiz­er, BioN­Tech seek au­tho­riza­tion of vac­cine for 5- to 11-year-olds; Fin­land halts roll­out of ...

4 years ago
Coronavirus

An­oth­er three biotechs are set to de­but on Nas­daq as com­bined in­dus­try raise tops $14B

4 years ago
Financing

Flag­ship turns to No­var­tis HR gu­ru in lat­est ad­di­tion; David Grainger sad­dles up to new po­si­tion at Centes­sa while ...

4 years ago
Peer Review

FDA's an­timi­cro­bial ad­comm unan­i­mous­ly backs Takeda's drug for post-trans­plant cy­tomegalovirus

4 years ago
Pharma
FDA+

Al­lo­gene hit with FDA clin­i­cal hold af­ter a pa­tient ex­pe­ri­ences 'ab­nor­mal­i­ty' in CAR-T cells — shares ham­mered

4 years ago
R&D
FDA+

New Eng­land-based dis­trib­u­tor HP­NE looks to dou­ble its work­force to keep up with de­mand

4 years ago
Outsourcing
Manufacturing

BioCi­na com­pletes takeover of Pfiz­er-owned Aus­tralia plant; Cam­brex adds space at NC site for small mol­e­cules

4 years ago
Manufacturing

Eli Lil­ly's re­cent­ly re­called glucagon kits were pro­duced at trou­bled In­di­anapo­lis site — re­port

4 years ago
Manufacturing

Schrödinger teams up with MD An­der­son on WEE1 in­hibitor pro­gram; Amid JAK safe­ty con­cerns, Ab­b­Vie touts new da­ta for ...

4 years ago
News Briefing

Bay­er drops $460M in­to con­tra­cep­tive man­u­fac­tur­ing sites with the Unit­ed Na­tion­s' back­ing

4 years ago
Manufacturing

Or­biMed's TKI play makes its Nas­daq de­but as The­seus prices IPO

4 years ago
Financing

Catal­ent opens newest clin­i­cal sup­ply site in Japan, ex­pand­ing its foot­print in the Pa­cif­ic Rim

4 years ago
Manufacturing

Biden's choice for FDA may be a wild card as top can­di­date says she's not in the run­ning

4 years ago
FDA+

Bris­tol My­er­s' TYK2 drug bombs ul­cer­a­tive col­i­tis test, but hopes are still high with pso­ri­a­sis fil­ing on deck

4 years ago
R&D

Em­bold­ened by a pos­i­tive PhI­II, No­var­tis steers a late-stage BTK in­hibitor in­to a piv­otal MS tri­al

4 years ago
R&D

As con­ti­nen­t's vac­ci­na­tion rate sits be­low 5%, Mod­er­na an­nounces in­vest­ment in mR­NA man­u­fac­tur­ing in Africa

4 years ago
Deals
Coronavirus

Sanofi, Mod­er­na beef up the case for giv­ing flu, Covid-19 vac­cines to el­der­ly in the same vis­it

4 years ago
R&D
Coronavirus
First page Previous page 639640641642643644645 Next page Last page
A service from the Financial Times